Ligand Pharmaceuticals (LGND) Tax Rate (2010 - 2026)
Ligand Pharmaceuticals (LGND) reported Tax Rate of 44.99% for Q1 2026, up 2959.0% on a YoY basis from 1.47% in Q1 2025, and up 112.95% sequentially from 21.13% in Q4 2025.
Ligand Pharmaceuticals (LGND) Tax Rate (2010 - 2026) Analysis & Trends
Ligand Pharmaceuticals (LGND) has 17 years of Tax Rate data on file, last reported at 44.99% in Q1 2026.
- For the quarter ending Q1 2026, Tax Rate rose 2959.0% year-over-year to 44.99%; the trailing twelve-month figure through Mar 2026 stood at 16.94% (down 74.0% YoY), and the FY2025 full-year result was 21.71%, down 23842.0% from the prior year.
- Tax Rate rose to 44.99% in Q1 2026, from 21.13% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 160.21% in Q4 2022 to a low of 45.47% in Q2 2022.
- A 5-year average of 21.24% and a median of 20.69% in 2024 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate soared 17273 bps in 2022 and tumbled 16659 bps in 2023, its largest moves.
- Tracing LGND's Tax Rate over 5 years: stood at 160.21% in 2022, then sank by 104 bps to 6.38% in 2023, then soared by 424 bps to 20.69% in 2024, then increased by 2 bps to 21.13% in 2025, then soared by 113 bps to 44.99% in 2026.
- Business Quant data shows LGND's Tax Rate at 44.99% in Q1 2026, 21.13% in Q4 2025, and 16.91% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn | 44.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.99% |
| Mar 31, 2026 | 44.99% |
| Mar 31, 2026 | 44.99% |
| Dec 31, 2025 | 21.13% |
| Dec 31, 2025 | 21.13% |
| Dec 31, 2025 | 21.13% |
| Sep 30, 2025 | 16.91% |
| Sep 30, 2025 | 16.91% |
| Sep 30, 2025 | 16.91% |
| Jun 30, 2025 | 56.81% |
| Jun 30, 2025 | 56.81% |
| Jun 30, 2025 | 56.81% |
| Mar 31, 2025 | 15.40% |
| Mar 31, 2025 | 15.40% |
| Mar 31, 2025 | 15.40% |
| Dec 31, 2024 | 20.69% |
| Dec 31, 2024 | 20.69% |
| Dec 31, 2024 | 20.69% |
| Sep 30, 2024 | -13.14% |
| Sep 30, 2024 | -13.14% |